Big pharma striving/struggling to reinvent itself - Recensione dipendente - Senior Scientist presso Sanofi

4,0
17 mag 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Decent benefit/salary Efforts from CEO and top management to bring more innovation Great colleagues Good work life balance

Svantaggi

HR is mostly contractors with constant turnover, so there is no system or real help for employees onboarding Bureaucracy that is inherent in the long history and French culture

Esplora altre recensioni su Sanofi

5,0
24 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

work life balance, benefits, flexibility

Svantaggi

less competitive salary, less promotion

3,0
1 lug 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Extensive and active employee resource groups, strong leadership development opportunities, clear company mission, gig opportunities that support career development, strong employee support through the ombuds office and compliance help line, and stable company portfolio.

Svantaggi

No work-life balance considerations with hybrid work model, contradictions in company mission compared to policies (i.e., target to reduce carbon emissions with employee commuting to office as one of the top 5 causes but yet still requiring employees to commute to office 3 days a week), some office sites are not conducive to in office productivity (not enough privacy or space), compensation package is not competitive for MA pharmaceutical companies, long-term incentives have almost no value once they are vested, health care benefits require employees to jump through hoops to maximize discounts or qualify for coverage of certain medications, and accountability for department leadership to follow the corporate leadership pillars is inconsistent across departments.

Vedi recensioni per: Utile|Valutazione|Data|Tutto